Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2023 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PTIX on Nasdaq
Shares outstanding
869,565
Price per share
$0.22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 3.4% $52,800 240,000 Armistice Capital, LLC 31 Dec 2024

Institutional Holders of Protagenic Therapeutics, Inc.\new - Common Stock, par value $0.0001 per share (PTIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$65,867 $0.22 0
2025 Q1 337,758 $65,867 +$26,004 $0.20 8
2024 Q4 149,911 $74,975 -$13,056 $0.50 8
2024 Q3 165,083 $104,268 -$9,585 $0.63 9
2024 Q2 159,784 $145,661 +$38,049 $0.91 10
2024 Q1 537,482 $12,064,088 +$11,878,150 $1.75 10
2023 Q4 113,178 $106,844 +$15,696 $0.99 9
2023 Q3 96,390 $179,453 -$2,007 $1.87 8
2023 Q2 97,197 $198,414 +$3,642 $2.03 9
2023 Q1 95,444 $164,193 +$164,193 $1.73 10